| Literature DB >> 29976295 |
Joseph J Maleszewski1, Melanie C Bois2, John P Bois3, Philip M Young4, John M Stulak5, Kyle W Klarich2.
Abstract
The intersection of oncological and cardiovascular diseases is an increasingly recognized phenomenon. This recognition has led to the emergence of cardio-oncology as a true subspecialty. This field is not simply limited to primary cardiac tumors or complications of chemotherapeutic medications. Rather, it also encompasses metastatic cardiovascular complications and secondary cardiovascular effects of the underlying neoplasia. This review will broadly cover primary and metastatic cardiac neoplasms, as well as secondary cardiovascular effects of extracardiac neoplasia (e.g., amyloidosis, carcinoid valvulopathy, and chemotherapeutic cardiotoxicities).Entities:
Keywords: masses; neoplasms; tumors
Mesh:
Year: 2018 PMID: 29976295 DOI: 10.1016/j.jacc.2018.05.026
Source DB: PubMed Journal: J Am Coll Cardiol ISSN: 0735-1097 Impact factor: 24.094